Literature DB >> 31607401

Intravitreal clindamycin as a therapeutic alternative in severe ocular toxoplasmosis.

L Tabuenca Del Barrio1, H Heras Mulero2, M Mozo Cuadrado2, P Fanlo Mateo3, E Compains Silva2.   

Abstract

Ocular toxoplasmosis is a disease than have severe consequences on the eyesight. The aim of this study article is to present a bilateral ocular toxoplasmosis in a sulfamide allergic patient with unilateral activation and her favourable progression with intravitreal Clindamycin and oral steroids treatment. Weekly intravitreal Clindamycin treatment is shown to be a suitable therapeutic alternative in cases of severe ocular toxoplasmosis and/or in patients with a contraindication to classical treatment. Intravitreal Clindamycin treatment is a safe alternative with favourable clinical results.
Copyright © 2019 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Chorioretinitis; Clindamicina intravítrea; Coriorretinitis; Intravitreal clindamycin; Toxoplasma gondii; Toxoplasmosis

Mesh:

Substances:

Year:  2019        PMID: 31607401     DOI: 10.1016/j.oftal.2019.09.005

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol (Engl Ed)        ISSN: 2173-5794


  1 in total

1.  Intravitreal Clindamycin as First-Line Therapy for Toxoplasmic Retinochoroiditis: A Case Series.

Authors:  Lalit Verma; Mithun Thulasidas; Avnindra Gupta
Journal:  Clin Ophthalmol       Date:  2020-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.